Diet containing dehulled adlay ameliorates hepatic steatosis, inflammation and insulin resistance in rats with non-alcoholic fatty liver disease

被引:6
|
作者
Yeh, Wan-Ju [1 ]
Ko, Jung [2 ]
Cheng, Wei-Yi [3 ]
Yang, Hsin-Yi [4 ]
机构
[1] Natl Taiwan Normal Univ, Grad Program Nutr Sci, Taipei, Taiwan
[2] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Tokyo, Japan
[3] Shou Univ, Dept Nutr, Kaohsiung, Taiwan
[4] Fu Jen Catholic Univ, Dept Nutr Sci, 510 Zhongzheng Rd, New Taipei 24205, Taiwan
关键词
Adlay; Fatty liver; Inflammation; Steatohepatitis; STEATOHEPATITIS; EXTRACT; STRESS; CYP2E1;
D O I
10.1017/S0007114521003366
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Dietary modification plays a vital role in the treatment of non-alcoholic liver diseases. We investigated the effects of the consumption of a different amount of dehulled adlay, which has hypolipidaemic and anti-inflammatory properties, on non-alcoholic fatty liver disease (NAFLD). We fed rats a high-fat-high-fructose liquid diet for 16 weeks to induce NAFLD. The rats were divided into three groups fed the NAFLD diet only (NN) or a diet containing 44 center dot 9 or 89 center dot 8 g/l of dehulled adlay (NA and NB groups, respectively). After 8 weeks, the NA and NB groups had lower C-reactive protein levels and improvement in insulin resistance. In addition, the NB group had lower liver weight and hepatic TAG and cholesterol concentrations than did the NN group. Compared with the NN group, the high-dose NB group had improved steatosis, lower hepatic TNF-alpha, IL-1 beta and IL-6 levels and lower adipose leptin levels. Our results suggest that a diet containing dehulled adlay can ameliorate NAFLD progression by decreasing of insulin resistance, steatosis and inflammation.
引用
收藏
页码:369 / 376
页数:8
相关论文
共 50 条
  • [1] Partial Replacement of Diet with Dehulled Adlay Ameliorates Hepatic Steatosis, Inflammation, Oxidative Stress, and Gut Dysbiosis in Rats with Nonalcoholic Fatty Liver Disease
    Huang, Hsuan-Chih
    Lee, Pei-Ni
    Huang, Wen-Chih
    Yang, Hsin-Yi
    NUTRIENTS, 2023, 15 (20)
  • [2] Hepatic ceramides dissociate steatosis and insulin resistance in patients with non-alcoholic fatty liver disease
    Luukkonen, Panu K.
    Zhou, You
    Sadevirta, Sanja
    Leivonen, Marja
    Arola, Johanna
    Oresic, Matej
    Hyotylainen, Tuulia
    Yki-Jarvinen, Hannele
    JOURNAL OF HEPATOLOGY, 2016, 64 (05) : 1167 - 1175
  • [3] Insulin resistance, inflammation, and non-alcoholic fatty liver disease
    Tilg, Herbert
    Moschen, Alexander R.
    TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2008, 19 (10): : 371 - 379
  • [4] The Mediterranean diet improves hepatic steatosis and insulin sensitivity in individuals with non-alcoholic fatty liver disease
    Ryan, Marno C.
    Itsiopoulos, Catherine
    Thodis, Tania
    Ward, Glenn
    Trost, Nicholas
    Hofferberth, Sophie
    O'Dea, Kerin
    Desmond, Paul V.
    Johnson, Nathan A.
    Wilson, Andrew M.
    JOURNAL OF HEPATOLOGY, 2013, 59 (01) : 138 - 143
  • [5] Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease
    Samuel, VT
    Liu, ZX
    Qu, XQ
    Elder, BD
    Bilz, S
    Befroy, D
    Romanelli, AJ
    Shulman, GI
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (31) : 32345 - 32353
  • [6] Interleukin-17 exacerbates hepatic steatosis and inflammation in non-alcoholic fatty liver disease
    Tang, Y.
    Bian, Z.
    Zhao, L.
    Liu, Y.
    Liang, S.
    Wang, Q.
    Han, X.
    Peng, Y.
    Chen, X.
    Shen, L.
    Qiu, D.
    Li, Z.
    Ma, X.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2011, 166 (02): : 281 - 290
  • [7] Non-alcoholic fatty liver disease and insulin resistance
    Machado, M
    Cortez-Pinto, H
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2005, 17 (08) : 823 - 826
  • [8] Allopurinol Ameliorates Non-Alcoholic Fatty Liver Disease in Rats
    Korkmaz, Huseyin Anil
    Aktug, Huseyin
    Atila, Dincer
    Barisik, Vatan
    Arslan, Nur
    Erbas, Oytun
    HORMONE RESEARCH IN PAEDIATRICS, 2018, 90 : 306 - 306
  • [9] Assessment of hepatic steatosis algorithms in non-alcoholic fatty liver disease
    Eremic-Kojic, N.
    Deric, M.
    Govorcin, M. L.
    Balac, D.
    Kresoja, M.
    Kojic-Damjanov, S.
    HIPPOKRATIA, 2018, 22 (01) : 10 - 16
  • [10] Assessment of hepatic steatosis algorithms in non-alcoholic fatty liver disease
    Kojic, N. Eremic
    CLINICA CHIMICA ACTA, 2019, 493 : S362 - S362